Taro Pharmaceutical Industries Ltd Revenue per Employee (TARO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Taro Pharmaceutical Industries Ltd  (NYSE: TARO)
 

Taro Pharmaceutical Industries Ltd's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 2.07% in the fourth quarter 2023, year on year to cumulative value of $573 million, Taro Pharmaceutical Industries Ltd's revenue per employee grew on a trailing twelve months basis to $ 133,245. The productivity of Taro Pharmaceutical Industries Ltd's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 288 other companies have achieved higher revenue per employee. While Taro Pharmaceutical Industries Ltd's total ranking has deteriorated compared to the previous quarter from 0 to 2662. Taro Pharmaceutical Industries Ltd has 4,300 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TARO Revenue per Employee (Mar 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Revenue Change 2.07 % - - - 2.25 %
Sales per Employee (TTM) $ 133,245 130,543 130,543 130,543 130,543
TARO's Total Ranking # 2662 # 0 # 0 # 0 # 2664
Seq. Revenue Change - - - - -

TARO Company Profile >> Back to TARO Efficiency Comparisons >> Compare TARO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 289
Overall Market # 2662

Revenue per Employee Statistics
High Average Low
$ 162,244 $ 116,756 $ 93,681
(Mar 31 2016)   (Mar 31 2021)



Financial Statements
Taro Pharmaceutical Industries Ltd's Revenue MRQ $ 573 Millions Visit TARO's Income Statement
Taro Pharmaceutical Industries Ltd's Revenues TTM $ 573 Millions Visit TARO's aggregate revenue growth
What are TARO's Sales? Visit TARO's Sales by Segment




Other Ratios
Taro Pharmaceutical Industries Ltd's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TARO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TARO's Competitors
Revenue per Employee for TARO's Suppliers
Revenue per Employee for TARO's Customers

You may also want to know
TARO's Sales Growth Rates TARO's Pe Price to earnings ratio TARO's Receivables Turnover Ratio TARO's Stock Quote
TARO's Net Income Growth Rates TARO's Ps Price to Sales ratio TARO's Sales per Employee TARO's Asset Turnover Ratio
TARO's Net Margin TARO's Pb Price to Book ratio TARO's Financial Strength Ratios TARO's Dividend Payout Ratio
Date modified: 2023-06-30T08:25:33+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2023Number of Employees Mar 31 2023
Twist Bioscience Corporation  232,730.34 $ 227.843  Million 979 
Neuropace Inc   232,622.01 $ 48.618  Million 209 
Electromed Inc   232,101.52 $ 45.724  Million 197 
Axogen inc   231,898.71 $ 144.241  Million 622 
Schrodinger Inc   231,851.76 $ 197.074  Million 850 
The Cooper Companies Inc   228,486.67 $ 3,427.300  Million 15,000 
Lensar Inc   228,466.67 $ 34.270  Million 150 
American Shared Hospital Services  227,862.07 $ 19.824  Million 87 
Aspira Women s Health inc   226,500.00 $ 8.607  Million 38 
Lifeloc Technologies Inc   223,313.45 $ 8.486  Million 38 
Nuwellis Inc   222,184.21 $ 8.443  Million 38 
Boston Scientific Corporation  221,118.64 $ 13,046.000  Million 59,000 
Immucell Corporation  219,380.89 $ 16.015  Million 73 
Quanterix Corporation  219,095.54 $ 103.194  Million 471 
Mannkind Corporation  216,898.65 $ 128.404  Million 592 
Orthopediatrics Corp  216,710.96 $ 130.460  Million 602 
Syneos Health Inc   216,545.16 $ 5,413.629  Million 25,000 
Apyx Medical Corp  215,409.76 $ 44.159  Million 205 
Sonendo Inc   214,589.11 $ 43.347  Million 202 
Envista Holdings Corporation  213,741.67 $ 2,564.900  Million 12,000 
Inmed Pharmaceuticals Inc  212,659.82 $ 2.339  Million 11 
Stereotaxis Inc   211,129.77 $ 27.658  Million 131 
Exagen Inc   210,904.55 $ 46.399  Million 220 
Labcorp Holdings Inc   210,787.14 $ 14,755.100  Million 70,000 
Biotricity Inc   209,544.72 $ 9.639  Million 46 
Oramed Pharmaceuticals Inc  207,923.08 $ 2.703  Million 13 
Charles River Laboratories International inc   207,690.56 $ 4,091.504  Million 19,700 
Talkspace Inc   205,272.58 $ 122.753  Million 598 
Tela Bio Inc   202,738.53 $ 44.197  Million 218 
Somalogic Inc   202,265.96 $ 95.065  Million 470 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.